Search

Previous study found a high content of kaempferol‐3‐O‐rutinoside (KR) in Lu'an GuaPian tea, however, the rat plasma protein binding and mechanism of KR for cardiovascular protection are unclear. Thus, we studied plasma protein binding using ultrafiltration followed by UPLC, and screened its inhibition against LPS‐induced inflammation injury in vitro as well as the underlying mechanism by molecular docking and western blot. KR showed over 74% plasma protein binding ratio. Furthermore, KR may act on the toll‐like receptor 4 (TLR4) and myeloid differentiation factor 88 (MyD88). In vitro experiments showed that KR decreases the overexpression of TLR4, MyD88, and nuclear factor‐κB (NF‐κB), which further validates the molecular docking results, suggesting that KR could block TLR4/MyD88/NF‐κB signaling. These results indicate that KR could be a potential active agent in the protection of myocardial injury. Practical applications: Health benefits of tea are largely dependent on the intake of flavonoids. Flavonoids are a group of compounds beneficial to cardiovascular disease and an important part of "functional foods." Lu'an GuaPian tea is mainly produced in Lu'an City, Anhui Province and is one of the top 10 famous teas in China. Kaempferol‐3‐O‐rutinoside in Lu'an GuaPian has good hypoglycemic effect, mainly manifested in a strong inhibition of α‐glucosidase and α‐amylase activities. Present study showed that kaempferol‐3‐O‐rutinoside could block TLR4/MyD88/NF‐κB signaling, suggesting that it could be a potential active agent in the protection of myocardial injury. [ABSTRACT FROM AUTHOR]